MERIT CRO’s Post

No matter the phase of your project, from pilot study to Phase IV post-market study, MERIT provides the expertise and technology to help you achieve your development goals. We seamlessly manage the imaging components of your trial, creating efficiencies for your #drugdevelopment. Check out summaries of two of our #ophthalmology case studies to learn more: https://lnkd.in/dPrVxdHZ #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch #casestudy #imagingsolutions

Lexitas CEO Jeanne Hecht discusses the state of clinical trial funding and provides specific advice for founders on how to structure the investor pitch. Having looked at many dozens of investor pitch decks, Jeanne has identified 5 areas where founders often fall short. Check out the great insights! _________________________ #ophthalmology #clinicaltrials #lifesciences

#ASCO2024 is fast approaching—meet with Colin Miller, PhD, FIPEM, CSci Bracken CEO and medical imaging expert. Connect with him directly on LinkedIn to book a meeting ahead of time—and learn how Bracken's strategic integrated approach can elevate your clinical trials by reading the case study here: https://lnkd.in/e4RN_9u7. See you at ASCO! #ASCO2024 #ClinicalTrials #MedicalImaging #OncologyResearch #Bracken #LifeSci

Surge's €7.5M Funding Round: A Boon for Telemedicine & African Healthcare   The successful €7.5 million fundraising by SurgeCare, a European company pioneering immune system decryption for precision medicine, caught my attention. While Surge itself isn't African, its focus on personalized healthcare solutions resonates deeply with Africa's evolving telemedicine and telehealth space.   Here's why this is exciting news: Precision medicine holds immense potential: Tailoring treatments based on individual needs can significantly improve healthcare outcomes, where access to specialized care is limited. Surge's advancements can inspire VC trends: This significant investment by Eurazeo and other partners could encourage more VC interest in telemedicine solutions across Africa, leading to increased innovation and funding. SurgeLab™M and PreCyte® offer promising applications: These innovations focused on acquiring individualized immune signatures and predicting post-operative complications align perfectly with the need for remote diagnostics and personalized care in telemedicine. A bright future for African health: Surge's success story is a testament to the growing importance of personalized healthcare solutions. I'm optimistic that this will pave the way for more telemedicine advancements in Africa, ultimately improving the health and well-being of the continent's population.   Kudos to the SurgeCare team! Their dedication to precision medicine inspires us all. #telemedicine #africa #healthcare #precisionmedicine #venturecapital

Join us on May 7th, as we share exciting updates on IBD Explore, including a live demo of the platform. For more info: https://lnkd.in/eQ6PqfZg #IBD #digitalpathology #precisionmedicine #ArtificialIntelligence #AIPoweredPathology #precisionpathology

Based on the modeling and simulations, Palisade has established dose levels and trial design for the Phase 1 clinical study of PALI-2108 for #UlcerativeColitis. The Phase 1 clinical study is on track to commence before year end, learn more: https://bit.ly/3SCaSW3

#EYPT looks forward to The Retina Society 57th Annual Meeting. Touchpoints include:      👁️ 12-month results from the #DAVIO2 wet AMD clinical trial   📈 #Comparison study of #TKIs being developed for intravitreal delivery & #efficacy data from the #DAVIO2 clinical trial    Attending? Stay tuned for more updates!   #InvestorNews

Instead of viewing #clinicaltrials and real-world evidence as two distinct entities, it is crucial to regard them as complementary to each other. https://lnkd.in/duxGHMmX

If you are a professional in the #lifescience field, don’t miss this video!👀 ICONICS products streamline your work, with features like support for #FDA21CFRPart11. The ICONICS Digital Solutions for Life Science featured in this video will revolutionize your work.

In this excellent Healio interview, Mitchell Dul, OD, highlights ANTERION’s unique features, such as its ease of use, patient friendliness, acquisition speed, accuracy, ability to monitor changes over time, and more. He also shares a real patient experience. As principal investigator of the Heidelberg Engineering ANTERION clinical trial, he has a unique perspective. “It gave me the opportunity to compare and contrast each of these modalities and it [ANTERION] is a game changer. It’s a different experience entirely." Watch the full interview here: https://lnkd.in/ecRXiTGD #HeidelbergEngineering #HeidelbergEngineeringUS #optometry #ophthalmology #ANTERION